MAXIDEX
Details
- Status
- Prescription
- First Approved
- 1962-06-20
- Routes
- OPHTHALMIC
- Dosage Forms
- SUSPENSION/DROPS, OINTMENT
MAXIDEX Approval History
What MAXIDEX Treats
9 indicationsMAXIDEX is approved for 9 conditions since its original approval in 1962. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Inflammatory Conditions
- Allergic Conjunctivitis
- Acne Rosacea
- Superficial Punctate Keratitis
- Herpes Zoster Keratitis
- Iritis
- Cyclitis
- Infective Conjunctivitis
Drugs Similar to MAXIDEX
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
MAXIDEX FDA Label Details
ProIndications & Usage
FDA Label (PDF)Steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe, such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation; corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies.
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.